MTW-18377-41446 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Dose 1 — Pfizer-BioNTech
2020-12-29
Registered in v-safe
2020-12-29
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-31
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-07
Dose 2 — Pfizer-BioNTech
2021-01-14
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-28
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-11
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-18
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-08
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-29
Dose 3 — Pfizer-BioNTech
2022-01-07
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Became pregnant - typical associated symptoms

MedDRA releases: 2024-11 · check-in free text available
2022-01-07
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-10
Call 1 — Left Voicemail
2022-10-29
Survey response — 12 months, dose 3
MedDRA: Herpes zoster, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Postpardum preeclampsia, Shingles

MedDRA releases: 2024-11 · check-in free text available
2022-10-29
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-10-31
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-31
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-07	Pfizer-BioNTech
3	2021-10-29	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 10 — 12 months, dose 2

2022-01-07

Symptoms: Became pregnant - typical associated symptoms

Release 12 — 12 months, dose 3

2022-10-29

Symptoms: Postpardum preeclampsia, Shingles

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Herpes zoster	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release